Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TONER study of adjuvant nivolumab toxicity after chemoradiotherapy and surgery for esophageal cancer
NL-OMON58252Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Feb 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Trial of nivolumab, sponsored by University Medical Center Groningen. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
Beyond the preview
Go deeper on NL-OMON58252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58252.